Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW September 19, 2022
Access to Prostate Cancer Clinical Trials: A County-Level Analysis

Access to Prostate Cancer Clinical Trials: A County-Level Analysis

From the Bansal Group, Public Health Sciences Division
Science Spotlight - May 16, 2022
Genomic attributes predict cancer treatment responsiveness

Genomic attributes predict cancer treatment responsiveness

From the Nelson Lab, Human Biology & Clinical Research Divisions
Science Spotlight - February 21, 2022
Building better lab models of human tumors

Building better lab models of human tumors

Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Hutch News - October 05, 2021
Using AI to identify potential COVID-19, cancer therapies

Using AI to identify potential COVID-19, cancer therapies

Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Hutch News - September 30, 2021
Untranslated, maybe, unappreciated, no more.

Untranslated, maybe, unappreciated, no more.

From the Hsieh Lab, Human Biology Division
Science Spotlight - August 16, 2021
Catching up with cancer as COVID-19 starts to ebb

Catching up with cancer as COVID-19 starts to ebb

Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
Hutch News - June 29, 2021
Projection of cancer screening on metastasis: A prostate cancer case study

Projection of cancer screening on metastasis: A prostate cancer case study

From the Etzioni Group, Public Health Sciences Division
Science Spotlight - March 15, 2021
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Hutch News - November 16, 2020
Last Modified, April 02, 2020